Community-Dwelling People Screened Positive for Dementia in Primary Care: A Comprehensive,Multivariate Descriptive Analysis Using Data from the DelpHi-Study
Restricted accessResearch articleFirst published online May 10, 2016
Community-Dwelling People Screened Positive for Dementia in Primary Care: A Comprehensive,Multivariate Descriptive Analysis Using Data from the DelpHi-Study
Background: Efficient help and care for people with dementia (PWD) is dependent on knowledge about PWD in primary care.
Objective:This analysis comprehensively describes community-dwelling PWD in primary care with respect to various dementia care specific variables.
Methods: The analyses are based on baseline data of the ongoing general practitioner-based, randomized, controlled intervention trial DelpHi-MV (Dementia: life- and person-centered help). 6,838 patients were screened for dementia in 136 GP practices; 17.1% were screened positive, 54.4% of those agreed to participate and data could be assessed in n = 516 subjects. We assessed age, sex, living situation, cognitive status, functional status, level of impairment, comorbidities, formal diagnosis of dementia, depression, neuropsychiatric symptoms, quality of life, utilization of medical support, and pharmacological therapy.
Results: Concerning clinical-, dementia-, and health-related variables, the sample under examination was on average mildly cognitively and functionally impaired (MMSE, m = 22.2; BADL, m = 3.7). A level of care was assigned in 38.0%. Depression was identified in 15.4% and other frequent comorbidities were high blood pressure (83.3%), coronary heart diseases (37.1%), cerebrovascular diseases (22.3%), among others. In 48.6%, neuropsychiatric symptoms were present in a clinically relevant severity. Pharmacological treatment with antidementia medication was received by 25.8% and antidepressant medication by 14.0%. Utilization of services was generally low.
Conclusion:The comprehensive description of people screened positive for dementia in primary care reveals a complex and unique population of patients. They are considerably underdiagnosed and in their majority mildly to moderately affected. More in-depth analyses are needed to study relations, associations and interactions between different variables.
LuckT, LuppaM, WeberS, MatschingerH, GlaesmerH, KonigHH, AngermeyerMC, Riedel-HellerSG (2008) Time until institutionalization in incident dementia cases–results of the Leipzig Longitudinal Study of the Aged (LEILA 75+). Neuroepidemiology31, 100–108.
3.
LuppaM, SikorskiC, LuckT, WeyererS, VillringerA, KonigHH, Riedel-HellerSG (2012) Prevalence and risk factors of depressive symptoms in latest life–results of the Leipzig Longitudinal Study of the Aged (LEILA 75+). Int J Geriatr Psychiatry27, 286–295.
4.
LuckT, Riedel-HellerSG, LuppaM, WieseB, WollnyA, WagnerM, BickelH, WeyererS, PentzekM, HallerF, MoeschE, WerleJ, EiseleM, MaierW, van denBH, KaduszkiewiczH (2010) Risk factors for incident mild cognitive impairment–results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe). Acta Psychiatr Scand121, 260–272.
5.
LuppaM, Riedel-HellerSG, SteinJ, LeichtH, KonigHH, van denBH, MaierW, SchererM, BickelH, MoschE, WerleJ, PentzekM, FuchsA, EiseleM, JessenF, TebarthF, WieseB, WeyererS (2012) Predictors of institutionalisation in incident dementia–results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe study). Dement Geriatr Cogn Disord33, 282–288.
6.
EichlerT, ThyrianJR, HertelJ, MichalowskyB, WuchererD, DreierA, TeipelS, HoffmannW (2015) Rates of formal diagnosis of dementia in primary care: The effect of screening. Alzheimers Dement (Amst)1, 87–93.
7.
PrinceM, BryceR, FerriC (2011) World Alzheimer Report 2011: The benefits of early diagnosis and intervention. Alzheimer’s Disease International (ADI), UK, –London.
8.
PrinceM, AlbaneseE, GuerchetM, PrinaM (2014) World Alzheimer Report 2014-Dementia and Risk Reduction, an analysis of protective and modifiable risk factors. Alzheimer’s Disease International (ADI), London, UK.
9.
KöhlerL, Meinke-FranzeC, HeinJ, FendrichK, HeymannR, ThyrianJR, HoffmannW (2014) Does an interdisciplinary network improve dementia care? Results from the IDemUck-Study. Curr Alzheimer Res11, 538–548.
10.
WübbelerM, ThyrianJR, MichalowskyB, ErdmannP, HertelJ, HolleB, GräskeJ, Schäfer-WalkmannS, HoffmannW (2015) How do people with dementia utilize primary care physicians and specialists within dementia networks? Results of the Dementia Networks in Germany (DemNet-D) study. Health Soc Care Community, 10.1111/hsc.12315
11.
WübbelerM, ThyrianJR, MichalowskyB, HertelJ, LaporteUF, Wolf-OstermannK, Schäfer-WalkmannS, HoffmannW (2015) Nonpharmacological therapies and provision of aids in outpatient dementia networks in Germany: Utilization rates and associated factors. J Multidiscip Healthc8, 229–236.
12.
Allianz für Menschen mit Demenz (2014) , Federal Ministry for Family Affairs, Senior Citizens, Women and Youth; Federal Ministery of Health. Alliance for people with dementia - The fields of action–Berlin.
FoxC, MaidmentI, Moniz-CookE, WhiteJ, ThyrianJR, YoungJ, KatonaC, Chew-GrahamCA (2013) Optimising primary care for people with dementia. Ment Health Fam Med10, 143–151.
15.
ThyrianJR, FissT, DreierA, BowingG, AngelowA, LuekeS, TeipelS, FlessaS, GrabeHJ, FreybergerHJ, HoffmannW (2012) Life- and person-centred help in Mecklenburg-Western Pomerania, Germany (DelpHi): Study protocol for a randomised controlled trial. Trials13, 56.
16.
CalabreseP, KesslerJ (2000) Screening for cognitive impairment in dementia - the DemTect procedure. Eur Neuropsychopharmacol10, 369.
17.
ThyrianJR, HoffmannW (2012) Dementia care and general physicians-a survey on prevalence, means, attitudes and recommendations. Cent Eur J Public Health20, 270–275.
18.
EichlerT, ThyrianJR, DreierA, WuchererD, KohlerL, FissT, BowingG, MichalowskyB, HoffmannW (2014) Dementia care management: Going new ways in ambulant dementia care within a GP-based randomized controlled intervention trial. Int Psychogeriatr26, 247–256.
19.
KesslerJ, MarkowitschHJ, DenzlerP (1990) Mini-Mental-Status-Test (MMST) [German Version], Beltz Test GmbH, Göttingen.
20.
ErzigkeitH, LehfeldH, Pena-CasanovaJ, BieberF, Yekrangi-HartmannC, RuppM, RappardF, ArnoldK, HindmarchI (2001) The Bayer-Activities of Daily Living Scale (B-ADL): Results from a validation study in three European countries. Dement Geriatr Cogn Disord12, 348–358.
21.
HindmarchI, LehfeldH, de JonghP, ErzigkeitH (1998) The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord9(Suppl 2), 20–26.
22.
GauggelS, BirknerB (1999) Validity and reliability of a German version of the Geriatric Depression Scale (GDS). Z Klin Psychol Forsch Prax28, 18–27.
23.
YesavageJA, BrinkTL, RoseTL, LumO, HuangV, AdeyM, LeirerVO (1982) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res17, 37–49.
24.
CummingsJL (1997) The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology48, S10–S16.
25.
FissT, ThyrianJR, WuchererD, AssmannG, KilimannI, TeipelSJ, HoffmannW (2013) Medication management for people with dementia in primary care: Description of implementation in the DelpHi study. BMC Geriatr13, 121.
26.
GKV-Arzneimittelindex im Wissenschaftlichen Institut der AOK (WidO) des AOK-Bundesverbandes GbR
(2014) Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen. Amtliche Fassung des ATC-Index mit DDD-Angaben für Deutschland im Jahre, 2014.
27.
LarocheML, CharmesJP, BouthierF, MerleL (2009) Inappropriate medications in the elderly. Clin Pharmacol Ther85, 94–97.
28.
HoltS, SchmiedlS, ThurmannPA (2010) Potentially inappropriate medications in the elderly: The PRISCUS list. Dtsch Arztebl Int107, 543–551.
29.
StataCorp
(2009) Stata Statistical Software: Release 11.
30.
ZieglerU, DoblhammerG (2009) Prevalence and incidence of dementia in Germany–a study based on data from the public sick funds in 2002. Gesundheitswesen71, 281–290.
MichalowskyB, ThyrianJR, EichlerT, HertelJ, WuchererD, FlessaS, HoffmannW (2015) Economic analysis of formal care, informal care, and productivity losses in primary care patients who screened positive for dementia in Germany. J Alzheimers Dis50, 47–59.
34.
ThyrianJR, EichlerT, PoochA, AlbuerneK, DreierA, MichalowskyB, WuchererD, HoffmannW (2016) Systematic, early identification of dementia and dementia care management are highly appreciated by general practitioners in primary –results within a cluster-randomized-controlled trial (DelpHi). J Multidiscip Healthc, in press.
35.
SchulzeJ, GlaeskeG, van denBH, KaduszkiewiczH, KollerD, WieseB, HoffmannF (2013) Prescribing of antipsychotic drugs in patients with dementia: A comparison with age-matched and sex-matched non-demented controls. Pharmacoepidemiol Drug Saf22, 1308–1316.
36.
ChildA, ClarkeA, FoxC, MaidmentI (2012) A pharmacy led program to review anti-psychotic prescribing for people with dementia. BMC Psychiatry12, 155.
37.
LaitinenML, BellJS, LavikainenP, LonnroosE, SulkavaR, HartikainenS (2011) Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer’s disease in Finland. Int Psychogeriatr23, 1623–1631.
38.
KolanowskiA, FickD, WallerJL, AhernF (2006) Outcomes of antipsychotic drug use in community-dwelling elders with dementia. Arch Psychiatr Nurs20, 217–225.
